Search Results - "Real, L M"

Refine Results
  1. 1

    High frequency of potential interactions between direct‐acting antivirals and concomitant therapy in HIV/hepatitis C virus‐coinfected patients in clinical practice by Macías, J, Monge, P, Mancebo, M, Merchante, N, Neukam, K, Real, LM, Pineda, JA

    Published in HIV medicine (01-08-2017)
    “…Objectives The aim of the study was to analyse the frequency and degree of potential drug−drug interactions (DDIs) between direct‐acting antivirals (DAAs) and…”
    Get full text
    Journal Article
  2. 2

    Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain by Gonzalez‐Serna, A, Macias, J, Palacios, R, Gómez‐Ayerbe, C, Tellez, F, Rivero‐Juárez, A, Fernandez, M, Santos, J, Real, LM, Gonzalez‐Domenech, CM, Gomez‐Mateos, J, Pineda, JA

    Published in HIV medicine (01-05-2021)
    “…Objectives Spain is close to HCV microelimination, so rates of recently acquired HCV infection (RAHC) should decrease. Nowadays, men who have sex with men…”
    Get full text
    Journal Article
  3. 3

    Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV‐infected patients by Macías, J, Real, LM, Rivero‐Juárez, A, Merchante, N, Camacho, A, Neukam, K, Rivero, A, Mancebo, M, Pineda, JA

    Published in HIV medicine (01-11-2016)
    “…Objectives There are scant data on the progression of hepatic steatosis (HS) in HIV infection. We therefore evaluated changes in HS over time in HIV‐infected…”
    Get full text
    Journal Article
  4. 4

    Fat mass and obesity‐associated gene variations are related to fatty liver disease in HIV‐infected patients by Núñez‐Torres, R, Macías, J, Rivero‐Juarez, A, Neukam, K, Merino, D, Téllez, F, Merchante, N, Gómez‐Mateos, J, Rivero, A, Pineda, JA, Real, LM

    Published in HIV medicine (01-09-2017)
    “…Objectives Fatty liver disease (FLD) is frequently observed in HIV‐infected patients. Obesity and type 2 diabetes mellitus (T2DM) are strongly associated with…”
    Get full text
    Journal Article
  5. 5

    Association of genetic markers within the KIT and KITLG genes with human male infertility by Galan, J.J., De Felici, M., Buch, B., Rivero, M.C., Segura, A., Royo, J.L., Cruz, N., Real, L.M., Ruiz, A.

    Published in Human reproduction (Oxford) (01-12-2006)
    “…There is much evidence involving the KIT tyrosine kinase receptor and its ligand KITLG in the survival and proliferation of germ cells. Animal models and…”
    Get full text
    Journal Article
  6. 6

    Identification of a 2244 base pair interstitial deletion within the human ESR1 gene in the Spanish population by Galan, J Jorge, Buch, B, Pedrinaci, S, Jimenez-Gamiz, P, Gonzalez, A, Serrano-Rios, M, Salinas, A, Rivero, M del Carmen, Real, L M, Royo, J L, Ruiz, A

    Published in Journal of medical genetics (01-07-2008)
    “…The ESR1 AGATA haplotype is composed of five markers located within introns 5 and 6 of the human oestrogen receptor 1 (ESR1) gene. This haplotype has been…”
    Get more information
    Journal Article
  7. 7

    GAB2 gene does not modify the risk of Alzheimer’s disease in Spanish APOE 4 carriers by Ramírez-Lorca, Reposo, Boada, M., Saez, M. E., Hernandez, I., Mauleon, A., Rosende-Roca, M., Martinez-Lage, P., Gutierrez, M., Real, L. M., Lopez-Arrieta, J., Gayan, J., Antunez, C., Gonzalez-Perez, A., Tarraga, L., Ruiz, A.

    Published in The Journal of nutrition, health & aging (01-03-2009)
    “…Objectives The genetic basis of Alzheimer’s disease (AD) is being analyzed in multiple whole genome association studies (WGAS). The GAB2 gene has been proposed…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome by González, A., Sáez, M.E., Aragón, M.J., Galán, J.J., Vettori, P., Molina, L., Rubio, C., Real, L.M., Ruiz, Agustín, Ramírez-Lorca, R.

    Published in Human reproduction (Oxford) (01-04-2006)
    “…BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. The aim of the present study was to investigate the…”
    Get full text
    Journal Article
  9. 9

    Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus by Santos, M., Corma-Gómez, A., Fernandez-Fuertes, M., González-Serna, A., Rincón, P., Real, L.M., Pineda, J.A., Macías, J.

    Published in The Journal of infection (01-01-2023)
    “…•There is a high burden of liver damage in people living with HIV in the post-HCV era.•Residual injury due to prior chronic HCV infection is an outstanding…”
    Get full text
    Journal Article
  10. 10

    Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection by Fernandez-Fuertes, M., Macías, J., Corma-Gómez, A., Rincón, P., Merchante, N., Gómez-Mateos, J., Pineda, J. A., Real, L. M.

    Published in Scientific reports (21-04-2020)
    “…Hepatic steatosis (HS) is frequently observed in HIV-infected patients. It is not known whether HIV infection is an independent risk factor for HS development…”
    Get full text
    Journal Article
  11. 11

    Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson’s disease by González-Pérez, A., Gayán, J., Marín, J., Galán, J. J., Sáez, M. E., Real, L. M., Antúnez, C., Ruiz, A.

    Published in Neurogenetics (01-07-2009)
    “…Whole-genome epistasis analysis may add a new layer of knowledge to whole-genome association studies, permitting the identification of new candidate genes…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient by REAL, L. M, JIMENEZ, P, KIRKIN, A, SERRANO, A, GARCIA, A, CANTON, J, ZEUTHEN, J, GARRIDO, F, RUIZ-CABELLO, F

    Published in Cancer Immunology, Immunotherapy (01-01-2001)
    “…Progressive tumor growth may be associated with suppression of the immune response. Many different mechanisms may contribute to immune evasion. We investigated…”
    Get full text
    Journal Article
  14. 14

    Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line by ABRIL, E, REAL, L. M, SERRANO, A, JIMENEZ, P, GARCIA, A, CANTON, J, TRIGO, I, GARRIDO, F, RUIZ-CABELLO, F

    Published in Cancer Immunology, Immunotherapy (01-10-1998)
    “…HC class I expression can be up-regulated by interferons (IFN) and other cytokines. Both IFNalpha and IFNgamma have been shown to exert their effects via a…”
    Get full text
    Journal Article
  15. 15

    Rural habitat as risk factor for hepatitis E virus seroconversion in HIV‐infected patients: A prospective longitudinal study by Rivero‐Juarez, A., Cuenca‐Lopez, F., Martinez‐Peinado, A., Camacho, A., Real, L. M., Frias, M., Gordon, A., Cantisán, S., Torre‐Cisneros, J., Pineda, J. A., Rivero, A.

    Published in Zoonoses and public health (01-11-2017)
    “…Summary Our objective was to determine the incidence and clinical manifestations of acute hepatitis E virus (HEV) in HIV‐infected patients. A prospective…”
    Get full text
    Journal Article
  16. 16

    Expression of HLA G in human tumors is not a frequent event by Miguel Real, Luis, Cabrera, Teresa, Collado, Antonia, Jimenez, Pilar, Garcia, Angel, Ruiz‐Cabello, Francisco, Garrido, Federico

    Published in International journal of cancer (17-05-1999)
    “…Expression of HLA G may be a way for tumor cells to escape immuno‐surveillance. HLA G is selectively expressed by extravillous trophoblast in the human…”
    Get full text
    Journal Article
  17. 17

    Association of low-density lipoprotein receptor genotypes with hepatitis C viral load by Caruz, A, Neukam, K, Rivero-Juárez, A, Herrero, R, Real, L M, Camacho, Á, Barreiro, P, Labarga, P, Rivero, A, Pineda, J A

    Published in Genes and immunity (01-01-2014)
    “…Several data suggest that low-density lipoprotein receptor (LDLR) is a co-receptor for hepatitis C virus (HCV). Soluble LDLR can inhibit HCV infectivity;…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection by Herrero, R, Real, L M, Rivero-Juárez, A, Pineda, J A, Camacho, Á, Macías, J, Laplana, M, Konieczny, P, Márquez, F J, Souto, J C, Soria, J M, Saulle, I, Lo Caputo, S, Biasin, M, Rivero, A, Fibla, J, Caruz, A

    Published in Genes and immunity (01-03-2015)
    “…HIV-1 induces activation of complement through the classical and lectin pathways. However, the virus incorporates several membrane-bound or soluble regulators…”
    Get full text
    Journal Article
  20. 20

    Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression by JIMENEZ, P, CANTON, J, CONCHA, A, CABRERA, T, FERNANDEZ, M, REAL, L. M, GARCIA, A, SERRANO, A, GARRIDO, F, RUIZ-CABELLO, F

    Published in Cancer Immunology, Immunotherapy (01-03-2000)
    “…Down-regulation of the expression of major histocompatibility complex molecules is a frequent event that is associated with the poor immunogenicity of tumor…”
    Get full text
    Journal Article